세계 두개내출혈(ICH) 기기 시장 규모는 2023년 15억 9,000만 달러, 2030년까지 23억 5,000만 달러에 달할 것으로 예상되며, 2024-2030년의 예측 기간 동안 연평균 6.65% 성장할 전망입니다. 두개내출혈(ICH) 기기 수요 증가는 주로 뇌졸중, 뇌/뇌동맥류와 같은 뇌질환 환자 증가, 뇌질환을 앓고 있는 노인 인구의 부담 증가, 첨단 기술을 활용한 ICH 장치 개발에 대한 초점 전환으로 인해 2024-2030년의 예측 기간 동안 두개내출혈(ICH) 기기 시장 성장에 기여할 것입니다.
두개내출혈(ICH) 기기 시장 역학
두개내출혈(ICH) 기기 시장은 다양한 이유로 인해 제품 수요가 증가하고 있습니다. 제품 수요의 주요 요인은 전 세계적으로 뇌졸중, 뇌동맥류, 두개내 협착증과 같은 뇌 질환을 앓고 있는 환자들의 부담이 증가하고 있으며, 이러한 장치들은 최소 침습적 뇌신경 수술 기법을 사용하여 다양한 뇌 질환 및 질환을 치료하는 데 사용되기 때문에 두개내 출혈(ICH) 장치 수요를 촉진할 것으로 예상됩니다. 수요를 촉진할 것으로 예상됩니다.
예를 들어, Brain Aneurysm Foundation(2020)의 통계에 따르면, 매년 전 세계적으로 뇌동맥류로 인해 사망하는 사람은 거의 50만 명에 달하며, 피해자의 절반은 50세 미만이며, 특히 55세 이상 여성은 남성보다 뇌동맥류 파열 위험이 약 1.5배 더 높다(약 1.5배).
조사에 따르면, 미국에는 약 650만 명이 파열되지 않은 뇌동맥류가 있는 것으로 추산됩니다.
또한, 세계뇌졸중기구(World Stroke Organization, 2022)에 따르면 전 세계 25세 이상 성인 4명 중 1명이 평생 동안 뇌졸중을 앓게 될 것이라고 합니다. 전 세계적으로 매년 1,370만 명이 처음으로 뇌졸중을 앓고, 그 결과 550만 명이 사망합니다. 또한, 이 통계에 따르면 뇌졸중은 전 세계 사망과 장애의 주요 원인이며, 매년 1억 1600만 년의 건강 수명이 이 질환으로 인해 손실되고 있습니다.
이러한 뇌수술 수요 증가로 인해 두개내 출혈(ICH) 장치 수요는 예측 기간 동안 증가할 것으로 예상됩니다.
따라서 적절한 모니터링과 적절한 치료 및 약물 치료를 통해 이러한 결함을 예방할 수 있습니다. 따라서 두개내출혈(ICH) 기기 시장의 성장은 2024-2030년의 예측 기간 동안 성장할 것으로 예상됩니다.
그러나 두개내출혈(ICH) 기기와 관련된 위험과 장치 및 수술의 높은 비용은 두개내출혈(ICH) 기기 시장의 성장을 억제하는 요인으로 작용할 수 있습니다.
시장은 두개 내 출혈(ICH) 장치 사용에 영향을 미치는 COVID-19 발생에 직면했습니다. 두개 내 출혈은 매우 드물지만 코로나19의 합병증으로 잘 알려져 있습니다. 뇌졸중은 COVID-19의 증상으로 인정되며, 여러 연구에 따르면 COVID-19 환자의 0.9% - 23%가 뇌졸중이 발생했으며, COVID-19 환자는 혈전 형성 촉진 상태에 있으며 혈액이 두꺼워 지거나 끈적 거리는 경향이있어 뇌에 혈액을 공급하는 혈관이 막혀 뇌에 혈액을 공급합니다. 혈관이 막혀 뇌의 특정 부위에 혈액 공급이 차단되어 뇌경색 증상이 나타날 수 있습니다. 그 결과, 두개내출혈(ICH) 기기에 대한 수요가 증가했습니다.
두개내출혈(ICH) 기기 시장 부문별 분석
두개내출혈(ICH) 기기 시장의 제품 유형 부문에서는 신경내시경이 예측 기간(2024-2030년) 동안 높은 시장 점유율을 차지할 것으로 예상됩니다. 이는 이러한 장치가 뇌 모니터링에 있어 다양한 이점을 가지고 있기 때문인 것으로 보입니다. 이 장치는 최소 침습적 기술이며, 외과 의사가 두개골 내부에 위치하기 때문에 이전에는 수술이 불가능하다고 여겨졌던 뇌의 종양 및 기타 문제 영역에 도달하는 데 도움이 됩니다.
또한, 신경 내시경 검사는 코와 같은 선천적인 신체 구멍을 통해 시행할 수 있기 때문에 큰 절개가 필요하지 않습니다. 이 내시경의 끝에는 빛과 카메라가 달려있어 수술을 위해 뇌 내부를 더 잘 볼 수 있도록 도와주는 등의 장점이 있습니다.
이 보고서는 세계 두개내출혈(ICH) 기기 시장에 대해 조사 분석했으며, 시장 규모와 예측, 촉진요인 및 과제, 기업 및 제품 프로파일 등의 정보를 전해드립니다.
Intracranial Hemorrhage (ICH) Devices Market By Product Type (Diagnosis [Neuroendoscopes, Ct, Mri, Others], Treatment [Embolization Devices, Intracranial Stents, Balloon Occlusion Devices, Neurothrombectomy Devices, Others]), By End-User (Hospitals, Ambulatory Surgical Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising cases of brain disorders and growing geriatric population
Global Intracranial Hemorrhage (ICH) Devices Market was valued at USD 1.59 Billion in 2023, growing at a CAGR of 6.65% during the forecast period from 2024 to 2030 to reach USD 2.35 Billion by 2030. The increase in demand for Intracranial Hemorrhage (ICH) Devices is primarily attributed to the rising cases of brain disorders such as Stroke, Cerebral/Brain Aneurysm, the growing burden of the old age population suffering from brain disorders, shifting focus towards the development of technologically advanced ICH Devices, thereby contributing to the growth of the Intracranial Hemorrhage (ICH) Devices market during the forecast period from 2024-2030.
Intracranial Hemorrhage (ICH) Devices Market Dynamics:
The Intracranial Hemorrhage (ICH) Devices market is witnessing a growth in product demand owing to various reasons. The major reason responsible for product demand is due to the rising burden of the patient population suffering from brain disorders such as Stroke, Cerebral/Brain Aneurysm, Intracranial Stenosis, among others across the globe is expected to fuel the demand for Intracranial hemorrhage (ICH) Devices as these devices are used to treat various conditions and diseases of the brain using minimally invasive neurosurgical techniques.
For instance, according to the statistics of Brain Aneurysm Foundation 2020, there are almost 500,000 deaths worldwide each year caused by brain aneurysms, and half the victims are younger than 50, and women, particularly those over the age of 55, have a higher risk of brain aneurysm rupture than men (about 1.5 times the risk).
As per the same study, an estimated 6.5 million people in the United States have an un-ruptured brain aneurysm.
Moreover, according to the World Stroke Organization 2022, globally 1 in 4 adults over the age of 25 will have a stroke in their lifetime. 13.7 million people worldwide will have their first stroke each year and five and a half million will die as a result. Also, as per the same statistics, stroke is the leading cause of death and disability globally with 116 Million years of healthy life lost each year to the disease.
Thus, the rising prevalence of the target population is anticipated to raise the demand for brain surgeries thereby increasing the demand for Intracranial hemorrhage (ICH) Devices during the forecasted period.
Therefore, with proper monitoring, these defects can be prevented by undergoing proper care and medication. Hence, the growth of the Intracranial hemorrhage (ICH) Devices Market is expected to rise during the forecast period from 2024 to 2030.
However, the risk involved with Intracranial Hemorrhage (ICH) Devices and the high cost of equipment and surgeries may be certain limiting factors of the Intracranial Hemorrhage (ICH) Devices market growth.
The market witnessed a COVID-19 outbreak which impacted the use of Intracranial hemorrhage (ICH) Devices. Intracerebral hemorrhage is a very rare but well-documented complication of COVID-19. Stroke has been seen as a manifestation of COVID-19 in various studies showing that 0.9% to 23% of COVID-19 patients developed brain stroke. COVID-19 patients have a prothrombotic state which means they tend for the blood to thicken or become sticky which blocks the blood vessels supplying the brain; the blood supply of a particular part of the brain is cut off resulting in stroke symptoms. This resulted in the increased demand for Intracranial hemorrhage (ICH) Devices.
Intracranial Hemorrhage (ICH) Devices Market Segment Analysis:
Intracranial Hemorrhage (ICH) Devices Market By Product Type (Diagnosis [Neuroendoscopes, CT, MRI, Others], Treatment [Embolization Devices, Intracranial Stents, Balloon Occlusion Devices, Neurothrombectomy Devices, Others]), By End-User (Hospitals, Ambulatory Surgical Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the Product Type segment of the Intracranial Hemorrhage (ICH) Devices market, the Neuroendoscopes are estimated to hold a higher share in the Intracranial Hemorrhage (ICH) Devices market during the forecast period (2024-2030). This can be ascribed to the various advantages that are associated with these devices for the monitoring of the brain. These devices are minimally invasive techniques and help surgeons to reach tumors and other problematic areas inside the brain, previously considered inoperable due to their position inside the skull.
Moreover, since neuroendoscopy may be performed through natural body openings, such as the nose, it prevents the need for large incisions. Advantageous properties such as these endoscopes have a light and camera on the end, which helps in better visualization inside the brain for the surgery.
Moreover, the research and development activities in this arena will in turn drive the product demand in the market. For instance, in a clinical study, surgeons attached a fully charged smartphone to the front of a neuroendoscope, this provided visualization of the surgical field for use in minimally invasive neurosurgery.
Therefore, the advantages offered by the Neuroendoscopes such as minimal invasiveness, lower blood loss, and shorter surgical time in Intracranial hemorrhage surgeries are predicted to contribute to the increasing demand of the Intracranial hemorrhage (ICH) Devices market.
North America is expected to dominate the overall Intracranial Hemorrhage (ICH) Devices Market:
Among all the regions, North America is expected to account for the largest share in the global Intracranial Hemorrhage (ICH) Devices market. Factors such as the rising cases of brain disorders such as stroke, cerebral/brain aneurysm, rising incidences of intracranial hemorrhage are expected to aid in the growth of the North America Intracranial hemorrhage (ICH) Devices Market.
As per the Brain Aneurysm Foundation 2020, about 30,000 people in the United States suffer a brain aneurysm rupture each year. A brain aneurysm ruptures every 18 minutes. African-Americans and Hispanics are about twice as likely to have a brain aneurysm rupture compared to whites.
Moreover, the rising product approvals and new technologies such as the integration of AI in these devices in the country will boost the growth of the market.
For instance, in November 2022, FUJIFILM Healthcare Americas Corporation's REiLI® Artificial Intelligence Platform was used for clinical purposes for intracranial hemorrhage.
Therefore, the rising prevalence of these defects in the country would result in the rising demand for treatments that make use of Intracranial hemorrhage (ICH) Devices, which in turn would provide a conducive growth environment for the United States Intracranial hemorrhage (ICH) Devices market as well as the North American region.
Therefore, the interplay of various factors such as the presence of a large patient population, encouraging reimbursement policies as well as new product launches in the region is expected to boost the North America Intracranial hemorrhage (ICH) Devices market during the forecast period.
Intracranial Hemorrhage (ICH) Devices Market Key Players:
Some of the key market players operating in the Intracranial Hemorrhage (ICH) Devices market include ClearMind Biomedical Inc., Medtronic, Stryker, InfraScan, Inc., MicroPort Scientific Corporation, Penumbra, Inc., Acandis GmbH, Cerenovus (Johnson & Johnson Services, Inc.), MicroVention Inc. (Terumo Corporation), Invamed, B. Braun Melsungen AG, adeor medical AG, SCHINDLER Endoskopie Technologie, Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, Kaneka Medix Corporation, Hyperfine, General Electric Company, phenox GmbH, Perflow Medical Ltd., among others.
Recent Developmental Activities in the Intracranial Hemorrhage (ICH) Devices Market:
In February 2022, the FDA granted expanded indication to Infrascanner, a handheld device used for detecting traumatic supratentorial hematomas in adults, to include pediatric patients aged 2 years and older.
In May 2019, Stryker announced the Premarket Approval (PMA) of the Neuroform Atlas Stent System by the U.S. Food and Drug Administration (FDA).
Key Takeaways from the Intracranial Hemorrhage (ICH) Devices Market Report Study
Target Audience who can be benefited from this Intracranial Hemorrhage (ICH) Devices Market Report Study
Frequently Asked Questions For Intracranial Hemorrhage (ICH) Devices Market:
Intracranial hemorrhage encompasses four broad types of hemorrhage: epidural hemorrhage, subdural hemorrhage, subarachnoid hemorrhage, and intraparenchymal hemorrhage and ICH devices are medical devices used to diagnose and treat these dir=sorders.
Global Intracranial Hemorrhage (ICH) Devices Market was valued at USD 1.5 Billion in 2023, growing at a CAGR of 6.65% during the forecast period from 2024 to 2030 to reach USD 2.35 Billion by 2030.
The Intracranial Hemorrhage (ICH) Devices market is witnessing a positive market growth owing to the rising cases of brain disorders such as Stroke, Cerebral/Brain Aneurysm, the growing burden of the old age population suffering from brain disorders, shifting focus towards the development of technologically advanced ICH Devices are anticipated to bolster the market.
Some of the key market players operating in the Intracranial Hemorrhage (ICH) Devices market include ClearMind Biomedical Inc., Medtronic, Stryker, InfraScan, Inc., MicroPort Scientific Corporation, Penumbra, Inc., Acandis GmbH, Cerenovus (Johnson & Johnson Services, Inc.), MicroVention Inc. (Terumo Corporation), Invamed, B. Braun Melsungen AG, adeor medical AG, SCHINDLER Endoskopie Technologie, Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, Kaneka Medix Corporation, Hyperfine, General Electric Company, phenox GmbH, Perflow Medical Ltd. and others.
North America is expected to hold the highest share in the revenue in the Intracranial Hemorrhage (ICH) Devices market during the forecast period. Factors such as the rising cases of brain disorders such as stroke, cerebral/brain aneurysm, rising incidences of intracranial hemorrhage are expected to aid in the growth of the North America Intracranial Hemorrhage (ICH) Devices Market in this region.